Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT02823717
Other study ID # PERINEE COMPLET
Secondary ID
Status Active, not recruiting
Phase
First received
Last updated
Start date January 31, 2015
Est. completion date December 31, 2023

Study information

Verified date April 2023
Source Groupe Hospitalier Paris Saint Joseph
Contact n/a
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

Perineal tear grade III and IV are relatively common (1-10% of deliveries depending on the series), and are a source of potentially serious complications, even long time after delivery (especially disorders of anal continence, psychological trauma). If a number of risk factors are well described, the support arrangements at the time of delivery and the characteristics of the review Proctological remote delivery and its relationship to the clinical status of patients is little known and rarely studied. In maternity wards of the hospital Saint Joseph Paris and Cochin-Port Royal group, patients with a diagnosis of severe perineal tear was made are taken following load with common rules, both for the immediate repair for the remote monitoring. Patients of both sites are indeed encouraged to consult in proctology consultation in Saint Joseph 4-6 months of birth. The same support on both sites allows to consider the creation of a relatively homogeneous cohort in terms of support and consider an important recruitment. Moreover, the geographical proximity of the inclusions sites (maternity) with proctology service is likely to limit the risk of lost sight of.


Description:

Main objective / secondary: Describe exactly the operational management of severe perineal tear (grade III and IV), their context and the factors associated with them occurring, the results of clinical and paraclinical proctology examination carried away from the birth, and study their relationship with the clinical status of patients at 6 months, 1, 2 and 3 years of confinement. Methodology : Type prospective, multicentre, non-interventional Study duration: 6 years


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 186
Est. completion date December 31, 2023
Est. primary completion date January 31, 2018
Accepts healthy volunteers No
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria: - All patients over 18 years - Affiliated to the national system of social security, - Giving birth during the period of inclusion of the St. Joseph site or Port Royal for whom the diagnosis of severe perineal tear was done. Exclusion Criteria: - None

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
France Groupe Hospitalier Paris Saint Joseph Paris Ile-de-Francfe

Sponsors (1)

Lead Sponsor Collaborator
Groupe Hospitalier Paris Saint Joseph

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Assessment of change of Bristol Score The Bristol stool scale is a diagnostic medical tool designed to classify the form of human faeces into seven categories. It is used in both clinical and experimental fields. 6 months, 1, 2 and 3 years of birth
Primary Assessment of change of anal incontinence score The severity of fecal incontinence can be assessed by a scoring system which takes into account the type and frequency of incontinence as well as the extent to which it alters the patient's life. This can also be used to monitor the patient over time, especially after interventions. 6 months, 1, 2 and 3 years of birth
See also
  Status Clinical Trial Phase
Withdrawn NCT02770755 - Registry of Celution Device for Processing ADRCs and Healing in Muscle and Ligament Sports Injuries N/A
Recruiting NCT05206838 - Achilles Tendon for the Treatment of Gluteus Medius Insufficiency N/A
Withdrawn NCT02045888 - Safety and Feasibility of ADRCs (Adipose Derived Regenerative Cells) in Patients With Grade II Hamstring Tears Phase 1/Phase 2
Completed NCT00726245 - Plasma Rich in Growth Factors (PRGF) Treatment for Muscle Tear Phase 2/Phase 3
Recruiting NCT05694078 - Hand Therapy Approach on Lumbrical Muscle Tears in Sport Climbers N/A